NEW YORK ( TheStreet) -- CHANGE IN RATINGS, EPS

AAON ( AAON) upgraded to buy at TheStreet ratings.

Advanced Micro ( AMD) upgraded at Wells from Market Perform to Outperform. Company is guiding toward better near-term growth.

Aetna ( AET) target raised at Goldman to $53. Positive earnings call commentary. Maintain Buy rating.

Altria ( MO) price target raised at Goldman to $28. Costs saves a modest plus, but expect muted PM-USA profit in 2012. Neutral rating.

Avon ( AVP) downgraded at UBS from Buy to Neutral. $20 price target. Major concerns about ability to execute and two SEC investigations.

BE Aerospace ( BEAV) estimates raised at Goldman through 2011 following through this quarter's upside. Maintain $47 price target and Buy rating.

Bristol Myers Squibb ( BMY) target raised at UBS. BMY price target increased to $32. Launches still key, growth continues. Neutral rating.

Bunge ( BG) estimates, target reduced at Credit Suisse. BG estimates were cut through 2012. Agribusiness profits will likely be lower than expected. Outperform rating and new $72 price target.

Cameron ( CAM) estimates, target reduced at Credit Suisse. Shares of CAM now seen reaching $71. Estimates also cut, as the company is seeing slower growth in North America. Outperform rating.

Cerner ( CERN) estimates, target boosted at Credit Suisse. Shares of CERN now seen reaching $67. Higher sales are driving margin growth. Neutral rating.

Coca-Cola ( KO) rated new Buy at Deutsche. KO was initiated with a Buy rating. $75 price target. Growth potential remains highest in the emerging markets.

Community Health ( CYH) downgraded at Wells from Outperform to Market Perform. Admission rates have been hurt by Tenet's allegations.

Consolidated Edison ( ED) downgraded at Jefferies from Hold to Underperform. $51 price target. Competitors are more attractive ways to play this sector.

Deckers Outdoor ( DECK) numbers raised at Credit Suisse. Shares of DECK now seen reaching $122. Estimates also increased, as Ugg continues to drive growth. Outperform rating.

Dow Chemical ( DOW) estimates, target cut at Credit Suisse. DOW estimates were cut through 2012. Company is seeing lower demand across the board. Outperform rating and new $40 price target.

Dow Chemical estimates lowered at UBS through 2012. Third quarter was in line, but rough patch is coming. Maintain $38 price target and Buy rating.

If you liked this article you might like

7 Essential Rules for Investing in Tech Stocks

Wall Street Deflates in Pullback After Fed Excitement, No Records for Dow

Your Guide to Making a Lot of Money on the Driverless Car Boom